Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Increased HLA-E expression in white matter lesions in multiple sclerosis.
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Progress in multiple sclerosis genetics.
Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study.
The need for randomization in animal trials: an overview of systematic reviews.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.
Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Current and new directions in MRI in multiple sclerosis.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.
DRUG DELIVERY TO CNS: CHALLENGES AND OPPORTUNITIES WITH EMPHASIS ON BIOMATERIALS BASED DRUG DELIVERY STRATEGIES.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.

Pages